95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
23.92%
Revenue growth above 1.5x KGC's 12.32%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
42.28%
Gross profit growth above 1.5x KGC's 16.92%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
51.76%
EBIT growth above 1.5x KGC's 22.52%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
51.76%
Operating income growth above 1.5x KGC's 22.52%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
41.64%
Net income growth above 1.5x KGC's 22.99%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
37.50%
EPS growth above 1.5x KGC's 18.75%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
37.50%
Diluted EPS growth 1.25-1.5x KGC's 26.67%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
0.11%
Share count expansion well above KGC's 0.04%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.43%
Diluted share count expanding well above KGC's 0.04%. Michael Burry would fear significant dilution to existing owners' stakes.
-55.10%
Dividend reduction while KGC stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
50.27%
OCF growth above 1.5x KGC's 25.72%. David Dodd would confirm a clear edge in underlying cash generation.
49.75%
FCF growth similar to KGC's 46.76%. Walter Schloss would attribute it to parallel capital spending and operational models.
153.70%
Positive 10Y revenue/share CAGR while KGC is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
80.52%
5Y revenue/share CAGR above 1.5x KGC's 27.35%. David Dodd would look for consistent product or market expansions fueling outperformance.
48.97%
3Y revenue/share CAGR 1.25-1.5x KGC's 35.42%. Bruce Berkowitz might see better product or regional expansions than the competitor.
148.05%
10Y OCF/share CAGR above 1.5x KGC's 22.02%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
106.30%
5Y OCF/share CAGR is similar to KGC's 113.59%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
73.89%
3Y OCF/share CAGR under 50% of KGC's 172.79%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
65.93%
Positive 10Y CAGR while KGC is negative. John Neff might see a substantial advantage in bottom-line trajectory.
240.67%
Below 50% of KGC's 516.15%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
121.59%
Below 50% of KGC's 296.97%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
115.16%
Positive growth while KGC is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
15.09%
5Y equity/share CAGR 1.25-1.5x KGC's 12.64%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
7.84%
Below 50% of KGC's 31.77%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
102.78%
Dividend/share CAGR of 102.78% while KGC is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
0.17%
3Y dividend/share CAGR of 0.17% while KGC is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
144.82%
AR growth well above KGC's 60.66%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-0.70%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
2.37%
50-75% of KGC's 4.56%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-23.76%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-2.17%
We cut SG&A while KGC invests at 2.43%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.